The EMBO Journal is a peer-reviewed scientific journal focusing on full-length papers describing original research of general interest in molecular biology and related areas. The journal is published by Nature Publishing Group on behalf of the European Molecular Biology Organization.
Benign intestinal tumors with mutations that delete or inactivate two particular tumor-suppressing genes develop more quickly towards cancerous forms, according to new research from the Crick.
Jan 06, 2020
0
39
Scientists at Bristol studying the body's inflammatory response to wounds following cancer surgery or biopsy have found that these procedures may cause growth signals to be delivered to any remaining cancer or pre-cancerous ...
Jul 01, 2015
0
192
University of Florida Health researchers have uncovered more evidence of a link between the brain's stress response and a protein related to Alzheimer's disease.
Sep 16, 2015
0
79
Cancer cells play it dirty to get what they want. They are survival artists with a strong criminal streak. They surround themselves with a protective shield of extra-cellular material and then secure supply lines by attracting ...
Jul 02, 2015
0
48
Auditory neuroscientists discover bottleneck of information flow in the ear and pave the way for gene therapy of deafness. Publication in EMBO Journal.
Oct 13, 2015
0
17
A study conducted by the Spanish National Cancer Research Centre´s (CNIO) Genomic Instability Group, led by Óscar Fernández-Capetillo, describes for the first time in mammals, the role played by the SMC5/6 protein complex ...
Oct 07, 2015
0
9
As tumours develop, faults can pop up in what seems like a bewildering number of genes. And each time one cell becomes two, these mistakes can change and become more diverse.
Sep 08, 2015
0
11
Researchers in the United Kingdom and Denmark have studied the "see-through" larvae of zebrafish to reveal how wound healing leads to skin cancer. Live imaging shows neutrophils, the protective inflammatory cells of the body's ...
Jul 01, 2015
0
12
(Medical Xpress)—It was an exciting year in the medical research field, as teams across the world continued to strive for a deeper understanding of the human body and for ways to prevent or treat ailments. Some focused ...
MALT1 blockers have long been in clinical use for the treatment of blood cancers. A study suggests that these drugs could potentially also be developed as a treatment option for glioblastoma, the most common and lethal type ...
Nov 27, 2019
0
14
